Mavacamten’s therapeutic impact: cardiac-specific myosin inhibition in obstructive hypertrophic cardiomyopathy

Dear Editor, Obstructive hypertrophic cardiomyopathy (oHCM) is a hereditary cardiac condition, affecting 1 in about 500 individuals, characterized by an atypical thickening of the heart muscle, specifically the interventricular septum...

Authors

Esha Khan
Ahmad Shabbir
Laiba Yumn

Institutions

Nishtar Medical College and Hospital (PK)

Publication Details

Journal: Global Cardiology
Published: 2024-11-05
DOI: https://doi.org/10.4081/cardio.2024.48
Primary Topic: Cardiomyopathy and Myosin Studies
Type: article
Field-Weighted Citation Impact: 0.00

Controls

|||

ALL TIME

JAN

FEB

MAR

APR

MAY

JUN

JUL

AUG

SEP

OCT

article

Mavacamten’s therapeutic impact: cardiac-specific myosin inhibition in obstructive hypertrophic cardiomyopathy

Esha Khan, Ahmad Shabbir, Laiba Yumn

Nov 5, 2024

Global Cardiology

Cardiomyopathy and Myosin Studies

article

Mavacamten’s therapeutic impact: cardiac-specific myosin inhibition in obstructive hypertrophic cardiomyopathy

Esha Khan, Ahmad Shabbir, Laiba Yumn

November 5, 2024article en

Abstract

Global CardiologyVol. 2(3)

Nishtar Medical College and Hospital (PK)

Openalex Percentile: Top 64%

Cardiomyopathy and Myosin Studies

DOI Open Access PDF OpenAlex

AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Mavacamten’s therapeutic impact: cardiac-specific myosin inhibition in obstructive hypertrophic cardiomyopathy — Esha Khan, Ahmad Shabbir, et al. · Global Cardiology (2024) | TGRS Research Map | TGRS